StockVS

RadNet, Inc. (RDNT) 股票分析

医疗保健

RadNet, Inc.

$54.12

$-0.28 (-0.51%)

最后更新: 2026年5月26日

价格走势

分析

公司概述

RadNet, Inc. operates as a significant provider of outpatient diagnostic imaging services, delivering critical medical technologies such as magnetic resonance imaging, computed tomography, and positron emission tomography across the United States and international markets. The company functions within the Healthcare sector, specifically the Diagnostics & Research industry, positioning it as an essential infrastructure player in the broader healthcare ecosystem where demand is driven by demographic shifts and technological advancements. As of the latest data, RadNet commands a market capitalization of $4.34 billion and generates annual revenue of $2.04 billion, supported by a workforce of 8,844 employees. These valuation and revenue figures indicate that RadNet holds a substantial market position, reflecting its scale as a major entity capable of influencing regional diagnostic networks while maintaining operations sufficient to support nearly 9,000 staff members globally.

财务健康

RadNet reported a trailing twelve-month revenue of $2.04 billion alongside a net income loss of $18,652,000, while generating an EBITDA of $242.93 million. The substantial gap between positive EBITDA and negative net income reveals a cost structure heavily impacted by significant interest expenses and depreciation charges, which erode pre-tax profits before reaching the bottom line. Despite the reported net loss, the company maintains robust free cash flow of $180.29 million, indicating strong operational liquidity and financial flexibility to fund capital expenditures or debt servicing without relying on external financing. The company's margin profile displays a gross margin of 18.2% and an operating margin of 6.8%, contrasting sharply with a negative profit margin of -0.9%, which highlights the high fixed cost environment typical of capital-intensive imaging centers where operating efficiencies are vital. On the balance sheet side, RadNet holds $767.21 million in cash against total debt of $1.86 billion, resulting in a debt-to-equity ratio of 137.09% that characterizes a highly leveraged financial structure dependent on consistent cash generation. Short-term liquidity is supported by a current ratio of 1.76, suggesting the company possesses sufficient current assets to cover its short-term liabilities with a comfortable buffer. Return metrics further illustrate the financial reality, with a return on equity of 1.4% and a return on assets of 1.6%, indicating that management effectiveness in generating returns on shareholder capital and deployed assets remains low due to the leverage and current earnings contraction.

估值评估

The valuation metrics for RadNet show a trailing P/E ratio marked as N/A due to negative earnings, while the forward P/E stands at 55.36, implying that the market prices in significant future earnings recovery and growth expectations rather than current profitability. The price-to-book ratio is recorded at 3.97, indicating that the market values the company at a substantial premium of nearly four times its net asset book value, likely reflecting intangible assets, brand value, or growth potential not captured on the balance sheet. Alternative valuation measures such as a price-to-sales ratio of 2.13 and an EV/EBITDA of 23.45 provide additional context, suggesting investors are willing to pay a multiple of over two times revenue and roughly 23 times earnings before interest, taxes, depreciation, and amortization. Regarding price momentum, the 52-week trading range spans from a low of $46.76 to a high of $85.84, meaning the stock has experienced significant volatility over the past year. The beta value of 1.53 indicates that RadNet's stock price exhibits volatility approximately 53% higher than the broader market, making it a more sensitive instrument to market swings compared to low-beta utilities or consumer staples.

Growth & Income

RadNet demonstrated a revenue growth rate of 14.8% year-over-year, whereas earnings growth is listed as N/A due to the current net loss, implying that top-line expansion is currently decoupled from bottom-line profitability as the company navigates high interest costs. Since the company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, all generated earnings and cash flows are theoretically available for reinvestment into business growth, debt reduction, or share repurchases rather than being distributed to shareholders. This reinvestment strategy is necessary given the negative net income, as paying dividends would be unsustainable without a return to positive earnings. Overall, RadNet presents a profile characterized by double-digit revenue expansion but lacks immediate income generation, relying on future operational leverage and cost management to unlock profitability and potentially restore earnings growth in subsequent periods.

同行比较

RadNet, Inc. (RDNT) 在诊断与研究行业运营。以下是其与市值最接近的同行的比较:

公司 代码 市值 市盈率
RadNet, Inc. RDNT $4.28B N/A
Thermo Fisher Scientific Inc. TMO $166.55B 24.6
Danaher Corporation DHR $122.31B 33.4
IDEXX Laboratories, Inc. IDXX $43.95B 41.0

诊断与研究行业平均市盈率为32.5倍。RadNet, Inc.的市盈率为N/A。

本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。

关于RadNet, Inc.

RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretations of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.

公司简介以英文显示。

访问官网 →

关键指标

市值
$4.28B
市盈率
N/A
52周最高
$85.84
52周最低
$50.76
平均成交量
880.45K
Beta系数
1.43

数据由Yahoo Finance通过yfinance提供。每日更新。

公司信息

交易所
NASDAQ
国家
United States
员工数
11,000